FDA says ulcer drugs may raise diarrhea risk
FDA says ulcer drugs may raise diarrhea risk Reuters
View ArticleMerck to keep recording income from Astra drugs
Merck to keep recording income from Astra drugs Reuters
View ArticlePfizer paying AstraZeneca $250M for rights to nonprescription version of...
Pfizer paying AstraZeneca $250M for rights to nonprescription version of heartburn drug Nexium Yahoo/AP
View ArticlePfizer-AstraZeneca’s Nexium Deal. Win-Win for both Companies?
Pfizer-AstraZeneca’s Nexium Deal. Win-Win for both Companies? Motley Fool
View Article3rd Circuit pay-for-delay ruling sparks Nexium antitrust suits
3rd Circuit pay-for-delay ruling sparks Nexium antitrust suits Reuters
View ArticleCommon Acid Reflux Drugs May Lead To Heart Disease, New Research Suggests
Common Acid Reflux Drugs May Lead To Heart Disease, New Research Suggests Forbes
View ArticleJudge sweeps aside AstraZeneca shield against Nexium competitor
Judge sweeps aside AstraZeneca shield against Nexium competitor Fierce Pharma
View ArticleAstraZeneca, Generic Drugmakers Face Class Action on Nexium
AstraZeneca, Generic Drugmakers Face Class Action on Nexium Bloomberg/Businessweek
View Article5 Blockbuster Drugs Going Off Patent in 2014
5 Blockbuster Drugs Going Off Patent in 2014 Motley Fool
View ArticleStomach acid drugs may increase vitamin deficiency risk
Stomach acid drugs may increase vitamin deficiency risk Reuters
View Article[video]The Biggest Victims of the Patent Cliff in 2014
[video]The Biggest Victims of the Patent Cliff in 2014 Motley Fool
View ArticleHanmi does not infringe AstraZeneca's Nexium -U.S. appeals court
Hanmi does not infringe AstraZeneca's Nexium -U.S. appeals court Reuters
View ArticleAstraZeneca Says Nexium Is ‘Still Safe’ With Ranbaxy Ingredient
AstraZeneca Says Nexium Is ‘Still Safe’ With Ranbaxy Ingredient Wall St Cheat Sheet
View ArticleRanbaxy scrambles for ingredients to make generic Nexium
Ranbaxy scrambles for ingredients to make generic Nexium Yahoo/Reuters
View ArticleAstraZeneca unveils direct-to-patient Nexium sales to fend off generic rivals
AstraZeneca unveils direct-to-patient Nexium sales to fend off generic rivals Fierce Pharma
View ArticlePfizer Statement on U.S. FDA Approval of Over-the-Counter Nexium® 24HR
Pfizer Statement on U.S. FDA Approval of Over-the-Counter Nexium® 24HR Yahoo/BusinessWire
View ArticleDespite A Disappointing Performance, Pfizer Pins Its Hope On These Drugs
Despite A Disappointing Performance, Pfizer Pins Its Hope On These Drugs Seeking Alpha
View Article
